Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Similar documents
Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Aetna Better Health of Illinois Medicaid Formulary Updates

ALLERGIC CONJUNCTIVITIS AGENTS

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

2014 Step Therapy Criteria (List of Step Therapy Criteria)

ALLERGIC RHINITIS-NASAL

Step Therapy Requirements

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

ANTICONVULSANT STEP THERAPY

Step Therapy Requirements

TABLE OF CONTENTS (Click on a link below to view the section.)

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

TABLE OF CONTENTS (Click on a link below to view the section.)

Step Therapy Medications

Step Therapy Criteria 2019

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ANGIOTENSIN RECEPTOR BLOCKERS

2017 Step Therapy Criteria

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

March 2018 P & T Updates

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE

2014 Quantity Limits (QL) Criteria

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

TABLE OF CONTENTS (Click on a link below to view the section.)

ANTICONVULSANT THERAPY

Formulary Medical Necessity Program

TABLE OF CONTENTS (Click on a link below to view the section.)

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

OHIO MEDICAID PHARMACY COVERAGE

ATYPICAL ANTIPSYCHOTICS

2016 Step Therapy (ST) Criteria

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

JULY 2017 ADDITIONS. NP Thyroid 120mg NP Thyroid 15mg JUNE 2017 CHANGES

HEALTH SHARE/PROVIDENCE (OHP)

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

Step Therapy Requirements. Effective: 05/01/2018

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Step Therapy Requirements. Effective: 11/01/2018

Tribute 2018 Formulary 2018 Quantity Limit Criteria

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Criteria

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Save on your drugs with HealthyRx

STEP THERAPY IN MEDICARE PART D

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Step Therapy Requirements. Effective: 12/01/2016

Tribute 2018 Formulary 2018 Quantity Limit Criteria

FirstCarolinaCare Insurance Company. Step Therapy Requirements

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

Quarterly pharmacy formulary change notice

ANTICONVULSANTS. Details

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Quarterly pharmacy formulary change notice

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

Cigna Drug and Biologic Coverage Policy

ANTICONVULSANTS. Details

AETNA BETTER HEALTH January 2017 Formulary Change(s)

ANTICONVULSANTS. Details

Inhaled bronchodilators relax constricted airways and treat the noisy part of asthma: coughing, wheezing, choking and shortness of breath.

2018 Step Therapy (ST) Criteria

Drugs That Require Step Therapy (ST) Step Therapy Medications

Drugs That Require Step Therapy (ST) Step Therapy Medications

ACYCLOVIR OINT (CCHP2017)

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

Umpqua Health Alliance (OHP) Formulary Changes January 2018

ANTIDIABETIC AGENTS - MISCELLANEOUS

Step Therapy Requirements. Effective: 1/1/2019

2018 Step Therapy (ST) Criteria

AETNA BETTER HEALTH January 2017 Formulary Change(s)

Transcription:

Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1

Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2

Albenza ALBENZA TABLET 200 MG ORAL Requires use of Pyrantel or Ivermectin. When ST therapy requirements are not met, the criteria in the PA guideline must be met for approval. 3

Azopt ALBENZA TABLET 200 MG ORAL Requires use of Dorzolamide or Dorzolamide-Timolol for at least 30 days 4

Celecoxib celecoxib capsule 100 mg oral celecoxib capsule 200 mg oral celecoxib capsule 400 mg oral celecoxib capsule 50 mg oral Requires use of 3 different NSAID's. When ST therapy requirements are not met, the criteria in the PA guideline must be met for approval. 5

Combigan COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of Brimonidine or Timolol for at least 15 days 6

Diabetes BYDUREON PEN-INJECTOR 2 MG SUBCUTANEOUS BYDUREON SUSPENSION RECONSTITUTED ER 2 MG SUBCUTANEOUS BYETTA 10 MCG PEN SOLUTION PEN-INJECTOR 10 MCG/0.04ML SUBCUTANEOUS BYETTA 5 MCG PEN SOLUTION PEN- INJECTOR 5 MCG/0.02ML SUBCUTANEOUS GLYXAMBI TABLET 10-5 MG ORAL GLYXAMBI TABLET 25-5 MG ORAL INVOKANA TABLET 100 MG ORAL INVOKANA TABLET 300 MG ORAL JANUMET TABLET 50-1000 MG ORAL JANUMET TABLET 50-500 MG ORAL JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 100-1000 MG ORAL JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 50-1000 MG ORAL JANUMET XR TABLET EXTENDED RELEASE 24 HOUR 50-500 MG ORAL JANUVIA TABLET 100 MG ORAL JANUVIA TABLET 25 MG ORAL JANUVIA TABLET 50 MG ORAL JARDIANCE TABLET 10 MG ORAL JARDIANCE TABLET 25 MG ORAL JENTADUETO TABLET 2.5-1000 MG ORAL JENTADUETO TABLET 2.5-500 MG ORAL JENTADUETO TABLET 2.5-850 MG ORAL KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 2.5-1000 MG ORAL KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 5-1000 MG ORAL KOMBIGLYZE XR TABLET EXTENDED RELEASE 24 HOUR 5-500 MG ORAL ONGLYZA TABLET 2.5 MG ORAL ONGLYZA TABLET 5 MG ORAL SYNJARDY TABLET 12.5-1000 MG ORAL SYNJARDY TABLET 12.5-500 MG ORAL SYNJARDY TABLET 5-1000 MG ORAL SYNJARDY TABLET 5-500 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 10-1000 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 12.5-1000 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 25-1000 MG ORAL SYNJARDY XR TABLET EXTENDED RELEASE 24 HOUR 5-1000 MG ORAL TRADJENTA TABLET 5 MG ORAL VICTOZA SOLUTION PEN-INJECTOR 18 MG/3ML SUBCUTANEOUS Requires use of Metformin, or a Metformin-containing product, for at least 60 days. 7

Ezetimibe ezetimibe tablet 10 mg oral Requires use of a both Atorvastatin and Simvastatin 8

ICS/LABA Inhalers ADVAIR DISKUS AEROSOL POWDER BREATH ACTIVATED 100-50 MCG/DOSE INHALATION ADVAIR DISKUS AEROSOL POWDER BREATH ACTIVATED 250-50 MCG/DOSE INHALATION ADVAIR DISKUS AEROSOL POWDER BREATH ACTIVATED 500-50 MCG/DOSE INHALATION ADVAIR HFA AEROSOL 115-21 MCG/ACT INHALATION ADVAIR HFA AEROSOL 230-21 MCG/ACT INHALATION ADVAIR HFA AEROSOL 45-21 MCG/ACT INHALATION DULERA AEROSOL 100-5 MCG/ACT INHALATION DULERA AEROSOL 200-5 MCG/ACT INHALATION SYMBICORT AEROSOL 160-4.5 MCG/ACT INHALATION SYMBICORT AEROSOL 80-4.5 MCG/ACT INHALATION Requires use of Qvar HFA, Pulmicort Flexhaler, Flovent HFA, or Asmanex Twisthaler. 9

Isotretinoin MYORISAN CAPSULE 10 MG ORAL MYORISAN CAPSULE 20 MG ORAL MYORISAN CAPSULE 30 MG ORAL MYORISAN CAPSULE 40 MG ORAL ZENATANE CAPSULE 10 MG ORAL ZENATANE CAPSULE 20 MG ORAL ZENATANE CAPSULE 30 MG ORAL ZENATANE CAPSULE 40 MG ORAL Requires use of Doxycycline or Minocycline 10

Lice/Scabicides malathion lotion 0.5 % external spinosad suspension 0.9 % external Requires use of Permethrin or Pyrethrin 11

Linzess LINZESS CAPSULE 145 MCG ORAL LINZESS CAPSULE 290 MCG ORAL LINZESS CAPSULE 72 MCG ORAL Requires use of Lactulose, Dicyclomine or Miralax 12

Nasal Steroids mometasone furoate suspension 50 mcg/act nasal Requires use of 2 of the following: Fluticasone OTC, Budesonide OTC, or Triamcinolone OTC. Members age 2-3 years old are not subject to the step requirement 13

Omega 3 omega-3-acid ethyl esters capsule 1 gm oral Use of OTC Fish Oil for at least 60 days in the previous 130 days. 14

Ophthalmic Antihistamines azelastine hcl solution 0.05 % ophthalmic epinastine hcl solution 0.05 % ophthalmic olopatadine hcl solution 0.1 % ophthalmic olopatadine hcl solution 0.2 % ophthalmic Requires use of Ketotifen ophthalmic 15

Overactive Bladder tolterodine tartrate er capsule extended release 24 hour 2 mg oral tolterodine tartrate er capsule extended release 24 hour 4 mg oral tolterodine tartrate tablet 1 mg oral tolterodine tartrate tablet 2 mg oral trospium chloride er capsule extended Use of oxybutynin IR/ER for at least 30 days within the previous 130 days. 16

Paricalcitol paricalcitol capsule 1 mcg oral paricalcitol capsule 2 mcg oral paricalcitol capsule 4 mcg oral Requires use of Calcitriol 17

Rosiglitazone AVANDIA TABLET 2 MG ORAL AVANDIA TABLET 4 MG ORAL Requires use of Metformin in combination with Pioglitazone for at least 60 days 18

Rosuvastatin rosuvastatin calcium tablet 10 mg oral rosuvastatin calcium tablet 20 mg oral rosuvastatin calcium tablet 40 mg oral rosuvastatin calcium tablet 5 mg oral Requires use of atorvastatin for at least 60 days. 19

Rozerem ROZEREM TABLET 8 MG ORAL Requires use of Zolpidem and Temazepam in the last 130 days. 20

Savella SAVELLA TABLET 100 MG ORAL SAVELLA TABLET 12.5 MG ORAL SAVELLA TABLET 25 MG ORAL SAVELLA TABLET 50 MG ORAL SAVELLA TITRATION PACK 12.5 & 25 & 50 MG ORAL Requires use of Duloxetine for at least 60 days 21

Sklice SKLICE LOTION 0.5 % EXTERNAL Requires use of Malathion 22

Timolol Ophth Gel timolol maleate gel forming solution 0.25 % ophthalmic timolol maleate gel forming solution 0.5 % ophthalmic Requires use of Timolol Solution for at least 15 days 23

Topical Calcineurin Inhibitors ELIDEL CREAM 1 % EXTERNAL tacrolimus ointment 0.03 % external tacrolimus ointment 0.1 % external Requires use of 2 different topical Corticosteroids 24

Topical Retinoids adapalene cream 0.1 % external tretinoin cream 0.025 % external tretinoin cream 0.05 % external tretinoin cream 0.1 % external tretinoin gel 0.01 % external tretinoin gel 0.025 % external Requires use of OTC Differin 0.1% Gel 25

Uloric ULORIC TABLET 40 MG ORAL ULORIC TABLET 80 MG ORAL Requires use of Allopurinol, Colchicine, or Probenicid 26